SciELO - Scientific Electronic Library Online

 
vol.45 número3Adult mesenchymal stem cell therapy for myelin repair in Multiple SclerosisIn Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Biological Research

versión impresa ISSN 0716-9760

Resumen

FIGUEROA, Fernando E; CARRION, Flavio; VILLANUEVA, Sandra  y  KHOURY, Maroun. Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review. Biol. Res. [online]. 2012, vol.45, n.3, pp.269-277. ISSN 0716-9760.  http://dx.doi.org/10.4067/S0716-97602012000300008.

Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflammatory effects. While the clinical outcome in case reports and phase I-II trials seems occasionally striking, these limited results point to the need to perform controlled multicenter trials. Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.

Palabras clave : Mesenchymal stem cells; autoimmune diseases; cellular therapy.

        · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons